Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
50.02
+0.05 (0.10%)
Apr 25, 2025, 12:18 PM EDT - Market open
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $2.08 billion as of April 25, 2025. Its market cap has increased by 53.06% in one year.
Market Cap
2.08B
Enterprise Value
1.86B
1-Year Change
53.06%
Ranking
Category
Stock Price
$50.02
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $2.08B, an increase of 575.40%. That is a compound annual growth rate of 52.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 2.08B | -1.77% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | 839.84M | 172.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 771.53B |
| UnitedHealth Group | 384.97B |
| Johnson & Johnson | 370.54B |
| AbbVie | 333.12B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.40B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |